3 Biotech Stocks With Huge Catalysts This Fall

Do you ever get the feeling that something big is about to happen somewhere in the stock market? Well, you're probably right. In the biotechnology industry alone, a record 71 start-up drugmakers raised at least $50 million in their initial public offerings last year, and this year is shaping up to be even bigger.

With so many well-funded research teams out there, choosing a few to follow closely is more difficult than ever. To make things just a little easier, here are three of the most significant biotech catalysts on the way.

Image source: Getty Images.

Source Fool.com